AAAAAA

   
Results: 1-12 |
Results: 12
COLLAGEN-BINDING INDUCES CHANGES IN ITS PLATELET INTEGRIN RECEPTOR ALPHA(2)BETA(1)
Authors: GOFERDADOSH N KLEPFISH A SCHMILOWITZ H SHAKLAI M LAHAV J
Citation: N. Goferdadosh et al., COLLAGEN-BINDING INDUCES CHANGES IN ITS PLATELET INTEGRIN RECEPTOR ALPHA(2)BETA(1), Platelets, 9(3-4), 1998, pp. 197-201
ACTIVATED PROTEIN-C RESISTANCE IN PEDIATRIC INFLAMMATORY BOWEL-DISEASE
Authors: LEVINE A LAHAV J ZAHAVI I RAZ A DINARI G
Citation: A. Levine et al., ACTIVATED PROTEIN-C RESISTANCE IN PEDIATRIC INFLAMMATORY BOWEL-DISEASE, Journal of pediatric gastroenterology and nutrition, 26(2), 1998, pp. 172-174
DIFFERENTIATION-INDUCED CHANGES IN THE EXPRESSION OF THROMBOSPONDIN-1AND ITS RECEPTORS IN TUMOR-CELLS OF HEMATOPOIETIC ORIGIN
Authors: GOHAR O SHAKLAI M LAHAV J
Citation: O. Gohar et al., DIFFERENTIATION-INDUCED CHANGES IN THE EXPRESSION OF THROMBOSPONDIN-1AND ITS RECEPTORS IN TUMOR-CELLS OF HEMATOPOIETIC ORIGIN, Thrombosis and haemostasis, 1997, pp. 2255-2255
AFFINITY MODULATION IN PLATELET ALPHA-2-BETA-1 FOLLOWING LIGAND-BINDING
Authors: GOFFERDADOSH N KLEPFISH A SCHMILOWITZ H SHAKLAI M LAHAV J
Citation: N. Gofferdadosh et al., AFFINITY MODULATION IN PLATELET ALPHA-2-BETA-1 FOLLOWING LIGAND-BINDING, Thrombosis and haemostasis, 1997, pp. 2750-2750
LEVELS OF PROTEIN-C AND PROTEIN-S DO NOT DECLINE SUBSEQUENT TO FIRST-LINE CHEMOTHERAPY IN LYMPHOMA PATIENTS
Authors: BAIREY O GABBAY U BLICKSTEIN D STARK P PROKOCIMER M EPSTEIN O SHAKLAI M LAHAV J
Citation: O. Bairey et al., LEVELS OF PROTEIN-C AND PROTEIN-S DO NOT DECLINE SUBSEQUENT TO FIRST-LINE CHEMOTHERAPY IN LYMPHOMA PATIENTS, Hematological oncology, 15(3), 1997, pp. 121-127
METHYLATION OF TYPE-I COLLAGEN RESULTS IN THE FORMATION OF VERY SMALLFIBRILS THAT MAKE IT POSSIBLE TO STUDY COLLAGEN-INDUCED PLATELET ACTIVATION BY FLOW-CYTOMETRIC
Authors: WIERWILLE S LAHAV J RAUTERBERG J TROYER D BALLEISEN L KEHREL B
Citation: S. Wierwille et al., METHYLATION OF TYPE-I COLLAGEN RESULTS IN THE FORMATION OF VERY SMALLFIBRILS THAT MAKE IT POSSIBLE TO STUDY COLLAGEN-INDUCED PLATELET ACTIVATION BY FLOW-CYTOMETRIC, Blood, 90(10), 1997, pp. 3034-3034
LEVELS OF PROTEINS-C AND PROTEIN-S DO NOT DECLINE SUBSEQUENT TO FIRSTLINE CHEMOTHERAPY IN LYMPHOMA PATIENTS
Authors: BAIREY O GABBAY U BLICKSTEIN D STARK P PROKOCIMER M EPSTEIN O SHAKLAI M LAHAV J
Citation: O. Bairey et al., LEVELS OF PROTEINS-C AND PROTEIN-S DO NOT DECLINE SUBSEQUENT TO FIRSTLINE CHEMOTHERAPY IN LYMPHOMA PATIENTS, Blood, 90(10), 1997, pp. 349-349
AFFINITY MODULATION IN PLATELET ALPHA-2-BETA-1 FOLLOWING LIGAND-BINDING
Authors: GOFERDADOSH N KLEPFISH A SCHMILOWITZ H SHAKLAI M LAHAV J
Citation: N. Goferdadosh et al., AFFINITY MODULATION IN PLATELET ALPHA-2-BETA-1 FOLLOWING LIGAND-BINDING, Biochemical and biophysical research communications, 232(3), 1997, pp. 724-727
STATE-OF-THE-ART 1995
Authors: LAHAV J
Citation: J. Lahav, STATE-OF-THE-ART 1995, Thrombosis and haemostasis, 74(1), 1995, pp. 5-5
A HUMAN MONOCLONAL IGA AUTOANTIBODY-185 12 BEHAVES LIKE AN AUTOIMMUNEANTIPHOSPHOLIPID ANTIBODY/
Authors: YRON I SHOHAT L LAHAV J WITZ IP FISCH B
Citation: I. Yron et al., A HUMAN MONOCLONAL IGA AUTOANTIBODY-185 12 BEHAVES LIKE AN AUTOIMMUNEANTIPHOSPHOLIPID ANTIBODY/, Clinical and experimental immunology, 97(2), 1994, pp. 187-192
COMPLEX-FORMATION OF THROMBOSPONDIN WITH FIBRONECTIN OR HEPARIN PROTECTS IT FROM LOSS OF FUNCTION AND EXTENSIVE PROTEOLYTIC DEGRADATION
Authors: DARDIK R EPSTEIN O LAHAV J
Citation: R. Dardik et al., COMPLEX-FORMATION OF THROMBOSPONDIN WITH FIBRONECTIN OR HEPARIN PROTECTS IT FROM LOSS OF FUNCTION AND EXTENSIVE PROTEOLYTIC DEGRADATION, Thrombosis and haemostasis, 69(6), 1993, pp. 1084-1084
THE FUNCTIONS OF THROMBOSPONDIN AND ITS INVOLVEMENT IN PHYSIOLOGY ANDPATHOPHYSIOLOGY
Authors: LAHAV J
Citation: J. Lahav, THE FUNCTIONS OF THROMBOSPONDIN AND ITS INVOLVEMENT IN PHYSIOLOGY ANDPATHOPHYSIOLOGY, Biochimica et biophysica acta, 1182(1), 1993, pp. 1-14
Risultati: 1-12 |